Tamoxifen Acts as a Parietal Cell Protonophore.

Manning, E H; Lapierre, L A; Mills, J C; Goldenring, J R

Manning, E H; Lapierre, L A; Mills, J C; Goldenring, J R.

Affiliation

Manning EH; Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee; Epithelial Biology Center, Vanderbilt University Medical Center, Nashville, Tennessee; Nashville VA Medical Center, Nashville, Tennessee.
Lapierre LA; Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee; Epithelial Biology Center, Vanderbilt University Medical Center, Nashville, Tennessee; Nashville VA Medical Center, Nashville, Tennessee.
Mills JC; Division of Gastroenterology, Washington University School of Medicine, Washington University in St. Louis, St. Louis, Missouri; Department of Internal Medicine, Washington University School of Medicine, Washington University in St. Louis, St. Louis, Missouri; Department of Developmental Biology, Wa
Goldenring JR; Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee; Epithelial Biology Center, Vanderbilt University Medical Center, Nashville, Tennessee; Nashville VA Medical Center, Nashville, Tennessee; Department of Cell and Developmental Biology, Vanderbilt University Medical Cen

Cell Mol Gastroenterol Hepatol ; 10(3): 655-657.e1, 2020.

Article de En | MEDLINE | ID: mdl-32361017

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cellules pariétales gastriques / États précancéreux / Protons / Tamoxifène / Modèles animaux de maladie humaine Limites: Animals / Humans Langue: En Journal: Cell Mol Gastroenterol Hepatol Année: 2020 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google